Drugs Controller General of India Current Affairs, GK & News
An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI) is to take a final call on the recommendation. When approved, Sputnik will be the third COVID-19 vaccine to be available in India. Sputnik V Vaccine The ..
Category: Economy & Banking Current Affairs
The drugs controller general of India (DGCI) granted approval to Glenmark Pharmaceuticals to manufacture and market oral antiviral drug Favipiravir to treat mild and moderate COVID-19 cases in India. The drug will be marketed under the brand name ‘FabiFlu’. It is known to prevent the virus from replication. In Japan, the drug is sold under ..
Month: Current Affairs - June, 2020
On 5th June, 2020, the Drugs Controller General of India allowed Sun Pharmaceutical to conduct trial for the first phytopharmaceutical or plant based drug AQCH to treat covid-19 patients. The trial has begun by Sun pharmaceutical in collaboration with ICGEB New Delhi and CSIR IIIM Jammu with support by CSIR and DBT. Mumbai based Sun ..
The Drugs Controller General of India (DCGI) has granted permission to Indian firm to conduct Phase-I clinical trials for a Zika vaccine. It was announced by Union Minister of State (MoS) for Health and Family Welfare Ashwini Kumar Choubey in Lok Sabha. Zika Virus Zika Virus is vector borne diseases spread by Aedes egypti mosquito. ..